FDA's removal of Ozempic, Wegovy from drug shortage list upheld

A federal judge on Wednesday ruled that the Food and Drug Administration's (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the drugs, was lawful and that the agency acted correctly. U.S. District Court Judge Mark Pittman found that the Outsourcing Facilities Association (OFA), an organization...